The PXR is a drug target for chronic inflammatory liver disease.
about
Why we scratch an itch: the molecules, cells and circuits of itchPregnane X receptor as a target for treatment of inflammatory bowel disordersTargeting xenobiotic receptors PXR and CAR for metabolic diseasesSustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor ActivationAlleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitisHepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse.Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics.Targeting the pregnane X receptor in liver injury.Pregnane X receptor modulates the inflammatory response in primary cultures of hepatocytesRNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome.Nuclear receptors as drug targets in cholestatic liver diseases.Xenobiotic receptor humanized mice and their utility.Nuclear receptors in the cross-talk of drug metabolism and inflammation.PXR cross-talks with internal and external signals in physiological and pathophysiological responses.Bile acid receptors as targets for drug development.The role of bile acids in functional GI disorders.Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid.Functions of pregnane X receptor in self-detoxification.From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases.Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitisRetinoid X Receptor Antagonists
P2860
Q26865093-64F51724-0C55-4587-8047-B2FEB23D54D7Q26998347-4B353058-99CD-464B-B758-9344B0B946C4Q27011149-24B4C4A5-6E0C-4906-A9E0-5AD0C5932579Q27322581-CDBBFE0E-4E2F-4CC2-95BB-1C7248180308Q28481350-1D1D8D64-B5AF-4513-BE52-E14293D543FBQ33676704-17C9C19B-1C03-4062-B6B9-6B02763C8005Q33726321-C8B1C981-A1CD-4974-B934-431BEF747FEEQ35057368-EB6F98B9-341D-4505-BFD8-AE3E419EDFFDQ35156371-48097BBE-7131-4FC1-825A-E9361F75EF39Q35998854-0D53259B-F1D7-4C8E-8D4F-3301B770E8B6Q36786270-1D5E398D-F953-459D-924F-F06EB43D0CDBQ38061645-D1A1FBDB-FDFA-4D58-A7A1-E031202830D7Q38074993-4FEBB8AF-889B-4A24-A899-2E714B9F29C8Q38108791-2FA18546-D66D-4C3B-86B6-25B5D34D6149Q38132058-E547C45B-A5A1-4F8C-B2D2-5EAB8C93FE34Q38217671-6E9F286E-BD59-40B8-8230-81462126CFB2Q38980237-99655EEB-9F35-4674-B89D-A4499357375FQ39293482-5C745956-DF59-4013-A6D7-D7F600BFC87FQ39324093-24AD52D4-9B0B-427B-A63B-366DD47B0FB2Q46135644-3E8C7F06-DE23-4DBD-8B27-4DF4EEE2BDBBQ46474665-A7671E36-D1B3-4C7E-8FD4-242400110866Q53749471-DA61A2BC-853A-4E9C-B103-E2ECCB9F913CQ58702534-5260F4D7-3A5C-4EFE-B815-426F40D2F3A4Q58789337-59CF795B-639F-4D21-B98A-935B791BB618
P2860
The PXR is a drug target for chronic inflammatory liver disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The PXR is a drug target for chronic inflammatory liver disease.
@ast
The PXR is a drug target for chronic inflammatory liver disease.
@en
The PXR is a drug target for chronic inflammatory liver disease.
@nl
type
label
The PXR is a drug target for chronic inflammatory liver disease.
@ast
The PXR is a drug target for chronic inflammatory liver disease.
@en
The PXR is a drug target for chronic inflammatory liver disease.
@nl
prefLabel
The PXR is a drug target for chronic inflammatory liver disease.
@ast
The PXR is a drug target for chronic inflammatory liver disease.
@en
The PXR is a drug target for chronic inflammatory liver disease.
@nl
P2093
P2860
P1476
The PXR is a drug target for chronic inflammatory liver disease.
@en
P2093
Andrew Axon
David E Cowie
Derek A Mann
Dimitrios K Konstantinou
Harald Carlsen
Karen Wallace
Matthew C Wright
Matthew Koruth
Stephen J Hill
Steven A White
P2860
P304
P356
10.1016/J.JSBMB.2010.04.012
P577
2010-04-21T00:00:00Z